Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Mononucleotide, Nicotinamide
2. Nicotinamide Mononucleotide
1. Nicotinamide Mononucleotide
2. Nicotinamide Ribotide
3. Nmn(+)
4. 3-carbamoyl-1-(5-o-phosphono-beta-d-ribofuranosyl)pyridinium
5. Nicotinamide Ribonucleoside 5'-phosphate
6. Beta-delta-nmn
7. B-nmn
8. B-d-nmn
9. Schembl6858129
10. Chebi:14648
11. Dtxsid401175036
12. Zinc4228273
13. S5259
14. Q27108984
15. 3-(aminocarbonyl)-1-(5-o-phosphono-beta-d-ribofuranosyl)pyridinium
16. 3-carbamoyl-1-b-d-ribofuranosylpyridinium Hydroxide 5'-phosphate Inner Salt
17. 3-(aminocarbonyl)-1-(5-o-phosphono-b-d-ribofuranosyl)-pyridinium Hydroxide Inner Salt
18. 3-(aminocarbonyl)-1-(5-o-phosphono-b-d-ribofuranosyl)-pyridinium Inner Salt
19. 3-(aminocarbonyl)-1-(5-o-phosphono-beta-delta-ribofuranosyl)-pyridinium Inner Salt
20. 3-carbamoyl-1-beta-delta-ribofuranosylpyridinium Hydroxide 5'-phosphate Inner Salt
21. 3-(aminocarbonyl)-1-(5-o-phosphono-beta-delta-ribofuranosyl)-pyridinium Hydroxide Inner Salt
22. 75414-16-3
| Molecular Weight | 335.23 g/mol |
|---|---|
| Molecular Formula | C11H16N2O8P+ |
| XLogP3 | -3.4 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 335.06442747 g/mol |
| Monoisotopic Mass | 335.06442747 g/mol |
| Topological Polar Surface Area | 163 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 1 |
| Complexity | 457 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Nicotinamide Mononucleotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nicotinamide Mononucleotide, including repackagers and relabelers. The FDA regulates Nicotinamide Mononucleotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nicotinamide Mononucleotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nicotinamide Mononucleotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nicotinamide Mononucleotide supplier is an individual or a company that provides Nicotinamide Mononucleotide active pharmaceutical ingredient (API) or Nicotinamide Mononucleotide finished formulations upon request. The Nicotinamide Mononucleotide suppliers may include Nicotinamide Mononucleotide API manufacturers, exporters, distributors and traders.
click here to find a list of Nicotinamide Mononucleotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nicotinamide Mononucleotide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nicotinamide Mononucleotide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nicotinamide Mononucleotide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nicotinamide Mononucleotide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nicotinamide Mononucleotide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nicotinamide Mononucleotide suppliers with NDC on PharmaCompass.
Nicotinamide Mononucleotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nicotinamide Mononucleotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nicotinamide Mononucleotide GMP manufacturer or Nicotinamide Mononucleotide GMP API supplier for your needs.
A Nicotinamide Mononucleotide CoA (Certificate of Analysis) is a formal document that attests to Nicotinamide Mononucleotide's compliance with Nicotinamide Mononucleotide specifications and serves as a tool for batch-level quality control.
Nicotinamide Mononucleotide CoA mostly includes findings from lab analyses of a specific batch. For each Nicotinamide Mononucleotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nicotinamide Mononucleotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Nicotinamide Mononucleotide EP), Nicotinamide Mononucleotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nicotinamide Mononucleotide USP).
LOOKING FOR A SUPPLIER?
